Scarica l'app Stockscreener
0.8523
1.14%
-0.0137
Precedente Chiudi:
$0.866
Aprire:
$0.8757
Volume 24 ore:
837.64K
Relative Volume:
0.08
Capitalizzazione di mercato:
$83.73M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-12.03%
1M Prestazione:
+10.44%
6M Prestazione:
-76.22%
1 anno Prestazione:
-71.84%
Intervallo 1D:
$0.8531
$0.88
Intervallo di 1 settimana:
$0.856
$1.02
Portata 52W:
$0.6816
$7.2904
Atyr Pharma Inc Stock (ATYR) Company Profile
Nome
Atyr Pharma Inc
Settore
Industria
Telefono
(858) 731-8389
Indirizzo
10240 SORRENTO VALLEY ROAD, SAN DIEGO
Confronta ATYR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATYR
Atyr Pharma Inc
|
0.8546 | 84.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.65 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.80 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.69 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.38 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Atyr Pharma Inc Stock (ATYR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-09-15 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-09-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-09-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-09-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-02-18 | Iniziato | Leerink Partners | Outperform |
| 2025-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-10-04 | Iniziato | Wells Fargo | Overweight |
| 2024-09-05 | Iniziato | Jefferies | Buy |
| 2023-07-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-10-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-09-21 | Iniziato | Piper Sandler | Overweight |
| 2021-05-10 | Iniziato | Laidlaw | Buy |
| 2020-08-17 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | Iniziato | ROTH Capital | Buy |
| 2020-03-02 | Iniziato | Oppenheimer | Outperform |
| 2018-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2017-09-07 | Iniziato | Piper Jaffray | Overweight |
| 2016-12-13 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-12-16 | Iniziato | Citigroup | Neutral |
| 2015-06-01 | Iniziato | Citigroup | Buy |
| 2015-06-01 | Iniziato | JP Morgan | Overweight |
Mostra tutto
Atyr Pharma Inc Borsa (ATYR) Ultime notizie
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineATYR - MarketScreener
aTyr Pharma, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsATYR - Lelezard
Class Action Lawsuit Filed: aTyr Pharma, Inc. (ATYR)Join by December 8, 2025Contact Levi & Korsinsky - Stockhouse
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ATYR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages aTyr Pharma, - GlobeNewswire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
Is aTyr Pharma Inc. stock cheap at current valuation2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
What catalysts could drive aTyr Pharma Inc. stock higherMarket Sentiment Summary & Reliable Entry Point Alerts - newser.com
Real time breakdown of aTyr Pharma Inc. stock performance2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Is aTyr Pharma Inc. stock poised for growthGDP Growth & Weekly Market Pulse Alerts - newser.com
aTyr Pharma Inc. stock prediction for this weekGDP Growth & Verified High Yield Trade Plans - newser.com
Lost Money on aTyr Pharma, Inc. (ATYR)? Contact Levi & Korsinsky to Join Class Action Before December 8, 2025 - ACCESS Newswire
December 8, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ATYR - Bluefield Daily Telegraph
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) InvestorsLead Plaintiff Deadline on December 8, 2025 - Stockhouse
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) - GlobeNewswire
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - Newsfile
aTyr Pharma (ATYR) to Release Earnings on Thursday - MarketBeat
Relative strength of aTyr Pharma Inc. in sector analysisWeekly Trend Recap & Reliable Intraday Trade Plans - newser.com
What earnings revisions data tells us about aTyr Pharma Inc.July 2025 Breakouts & Fast Entry Momentum Alerts - newser.com
Will aTyr Pharma Inc. (471A) stock outperform benchmarksInsider Selling & Weekly Chart Analysis and Guides - newser.com
How aTyr Pharma Inc. (471A) stock reacts to stronger dollarPortfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel ... - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, - GlobeNewswire
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming ... - Caledonian Record
The Gross Law Firm Notifies aTyr Pharma, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – ATYR - GlobeNewswire
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming DeadlinesATYR - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors - GlobeNewswire
ATYR Shareholder Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged — Hagens Berman - Morningstar
Why aTyr Pharma Inc. stock could see breakout soonWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Ranking aTyr Pharma Inc. among high performing stocks via toolsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Is aTyr Pharma Inc. stock a defensive play in 2025Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Burned by aTyr Pharma, Inc.? Contact Levi & Korsinsky to SueWallSt and Fight Back - ACCESS Newswire
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Does aTyr Pharma Inc. show high probability of reboundPortfolio Gains Summary & Advanced Technical Analysis Signals - newser.com
Lawsuit filed for Investors who lost money with shares of aTyr Pharma, Inc. (NASDAQ: ATYR) - openPR.com
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportu - GuruFocus
Investors who lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about ... - Bluefield Daily Telegraph
Investors who lost money on aTyr Pharma, Inc.(ATYR) should - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma - MarketScreener
Statistical indicators supporting aTyr Pharma Inc.’s strengthProfit Target & Fast Moving Trade Plans - newser.com
Will aTyr Pharma Inc. stock go up soonRate Cut & Verified Momentum Watchlists - newser.com
How aTyr Pharma Inc. stock responds to policy changesJuly 2025 Closing Moves & Weekly Market Pulse Updates - fcp.pa.gov.br
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr ... - Black Hills Pioneer
Will aTyr Pharma Inc. stock benefit from upcoming earnings reports2025 Market Overview & Fast Gain Stock Trading Tips - fcp.pa.gov.br
ROSEN, LEADING INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Reminder: ATYR Investors Should Contact Robbins LLP for Information About Leading the aTyr Pharma, Inc. Class Action Lawsuit - Barchart.com
Atyr Pharma Inc Azioni (ATYR) Dati Finanziari
Non sono disponibili dati finanziari per Atyr Pharma Inc (ATYR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Atyr Pharma Inc Azioni (ATYR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SCHIMMEL PAUL | Director |
Oct 09 '25 |
Buy |
0.94 |
317,999 |
299,364 |
1,413,023 |
| Gross Jane A | Director |
Mar 17 '25 |
Buy |
4.00 |
3,750 |
15,000 |
9,750 |
| Broadfoot Jill Marie | Chief Financial Officer |
Feb 04 '25 |
Sale |
3.78 |
1,254 |
4,740 |
31,763 |
| DENYES NANCY | General Counsel |
Feb 04 '25 |
Sale |
3.78 |
899 |
3,398 |
26,555 |
0.03%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):